Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Augmenting CAR T cell mediated anti-tumor efficacy through genetic modification to secrete a novel cytokine IL-36γ
    Meeting Abstract

    Li, X.; Daniyan, A.; Lopez, A.; Purdon, T.; Brentjens, R.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib
    Meeting Abstract

    Byrd, J.; Wierda, W.; Davids, M.; Choi, M.; Furman, R.; Mato, A.; Zhou, L.; Verdugo, M.; Potluri, J.; Coutre, S.
    British Journal of Haematology (2019)

    Fulltext@MSK | Save
  • Indirect treatment comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukaemia
    Meeting Abstract

    Mato, A.; Follows, G.; Sail, K.; Diakite, I.; Nicoloso, D.; Dietz, B.; Maher, J.; Alexiou, D.; Chirikov, V.
    British Journal of Haematology (2019)

    Fulltext@MSK | Save
  • DASFREE: An 18-month update of dasatinib discontinuation in patients with chronic myeloid leukemia in chronic phase and deep molecular response
    Meeting Abstract

    Shah, N. P.; García-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casare, M. T.; Pane, F.; more...
    British Journal of Haematology (2019)

    Fulltext@MSK | Save
  • A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Atallah, E.; Berger, M.; Jurcic, J.; Roboz, G.; Tse, W.; Mawad, R.; Rizzieri, D.; Begna, K.; Orozco, J.; Craig, M.; more...
    Journal of Medical Imaging and Radiation Sciences (2019)

    Fulltext@MSK | Save
  • Adverse events, resource use, and economic burden associated with mantle cell lymphoma: A real-world assessment of privately insured patients in the United States
    Journal Article

    Goyal, R. K.; Nagar, S. P.; Kabadi, S. M.; Kaye, J. A.; Seal, B.; Mato, A. R.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
    Review

    Lee, D. W.; Santomasso, B. D.; Locke, F. L.; Ghobadi, A.; Turtle, C. J.; Brudno, J. N.; Maus, M. V.; Park, J. H.; Mead, E.; Pavletic, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CARs of the future
    Review

    Daniyan, A. F.; Brentjens, R. J.
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Exciting times in acute myeloid leukemia
    Editorial

    Tallman, M. S.
    Seminars in Hematology (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save